Deadline:
December 15, 2025
Location(s)
Belgium Finland Netherlands
Ghent, Joensuu, Groningen
Overview
The European Master's in Clinical Linguistics (EMCL) is an Erasmus Mundus Joint Master Degree (EMJMD) that has been running for over 20 years. The newest edition is offered by the universities of Eastern Finland (Finland), Ghent (Belgium) and Groningen (The Netherlands). We also collaborate with 23 excellent associated partners.
EMCL++ is a 24-month, 120 ECTS, full-time research master’s programme that provides students with training in clinical linguistics, neurolinguistics and psycholinguistics. We fund and prepare very talented and motivated students to carry out original research and to be widely employable in academia (PhD) and/or industry (e.g. neurotechnology, clinical sector).
Details
The aim of EMCL++ is to train highly qualified advanced students who will be widely employable. Not only are students excellently prepared for research work and PhD programmes in the above fields, they will also be widely employable in the R&D and clinical sector, thanks to the inclusion of representatives from these sectors as associated partners in the programme.
EMCL+ is an integrated two-year Master’s programme offered jointly by a consortium of
- University of Groningen (NL)
- University of Eastern Finland (FI)
- Ghent University (BE) and
- 23 associated partners from the academic, R&D, and clinical sector, finishing with a joint MSc degree from the three institutions.
It is a full-time interdisciplinary and transnational university programme at the Masters level, providing integrated training in neurolinguistics, psycholinguistics, and clinical linguistics.
The aim of the Masters Course is to train highly qualified and advanced students who are excellently prepared for wide employability, by the unique combination of research training and an internship with an academic, R&D in neurotechnology, or clinical component.
This is a prerequisite for interdisciplinary research in the fields of neurolinguistics and clinical linguistics and it shapes practitioners with a solid theoretical and experimental approach. The regular study period is 24 months. It consists of four semesters: three teaching semesters and a fourth semester to finish the internship and Masters thesis.
Main objectives of the EMCL++ programme
The European Master’s in Clinical Linguistics+ (EMCL++) is the successor to the European Master’s in Clinical Linguistics (EMCL) and EMCL+ that were awarded the Erasmus Mundus label in 2004 and 2009. In the new programme we build on our past experiences and look ahead: we wish to continue this master’s programme which has excellent content, and tailor it to meet the requirements of the employment market.
From the time of its conception in 1997, the EMCL (first enrolments 1999) was constructed to be an integrated, transnational, and transdisciplinary master’s programme in neurolinguistics and clinical linguistics.
Looking ahead, we would like to maintain the excellence of this master’s course but also broaden the employment opportunities for our graduates, thereby making the programme more sustainable and creating capacity for the labour market.
Therefore, the objectives of the EMCL++ programme are to offer a joint, full-time interdisciplinary and transnational university programme at the Masters level providing integrated training in neurolinguistics and clinical linguistics to prepare the students to employment in the academic, R&D and clinical field. To achieve this we are joining forces with academic partners with complementary expertise and from related disciplines and non-academic partners from the R&D (neurotechnology) and the clinical sector.
These associated partners have been selected because they are stakeholders and future employers. In EMCL++ an internship at one of these associated partners will be mandatory.
These internships will offer European students the opportunity to obtain experience worldwide: they can do an internship at one of the academic partners in programme countries:
- Australia (Macquarie University, Sydney; MQ);
- USA (City University, New York; CUNY); and
- Russia (Higher School of Economics, Moscow; HSE).
Opportunity is About
Eligibility
Candidates should be from:
Description of Ideal Candidate
Both European and non-European students are eligible for scholarships.
Needed qualifications
Candidates should have at least three years of higher education (BA, BSc or equivalent) with an emphasis on one or more of the following:
- Speech and language pathology
- Linguistics
- Biomedical sciences
- Psychology
- Special education
In addition, candidates must be fluent in spoken and written English.
If you have questions about EMCL+ please contact: info@emcl.eu.
Dates
Deadline: December 15, 2025
Cost/funding for participants
EMJMD scholarships
There is no separate application form for scholarships. All students' applications will be evaluated by a selection committee and ranked; the EU will then check and officially confirm the ranking list, issuing scholarships to the highest ranked students.
-
Total scholarship amount for Programme Country student: 35,000€
-
Total scholarship amount for Partner Country student: 49,000€
If you get accepted into the programme but are not selected for a scholarship you might want to apply on your own for external funding, e.g. at your national funding agency.
Un-save Opportunity
Internships, scholarships, student conferences and competitions.
